These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 10950879
1. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. Styren SD, Hamilton RL, Styren GC, Klunk WE. J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879 [Abstract] [Full Text] [Related]
4. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Ikeda S, Allsop D, Glenner GG. Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985 [Abstract] [Full Text] [Related]
5. Modification of methods to use Congo-red stain to simultaneously visualize amyloid plaques and tangles in human and rodent brain tissue sections. Sarkar S, Raymick J, Cuevas E, Rosas-Hernandez H, Hanig J. Metab Brain Dis; 2020 Dec; 35(8):1371-1383. PubMed ID: 32852699 [Abstract] [Full Text] [Related]
8. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Czasch S, Paul S, Baumgärtner W. Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188 [Abstract] [Full Text] [Related]
9. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease. Sun A, Nguyen XV, Bing G. J Neurosci Methods; 2001 Oct 15; 111(1):17-27. PubMed ID: 11574116 [Abstract] [Full Text] [Related]
12. New temperature modification makes the Bielschowsky silver stain reproducible. Litchfield S, Nagy Z. Acta Neuropathol; 2001 Jan 15; 101(1):17-21. PubMed ID: 11194935 [Abstract] [Full Text] [Related]
13. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex. Yilmazer-Hanke DM. Acta Anat (Basel); 1998 Jan 15; 162(1):46-55. PubMed ID: 9789108 [Abstract] [Full Text] [Related]
14. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients. van de Nes JA, Konermann S, Nafe R, Swaab DF. Acta Neuropathol; 2006 Feb 15; 111(2):126-38. PubMed ID: 16456666 [Abstract] [Full Text] [Related]
15. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Cummings BJ, Pike CJ, Shankle R, Cotman CW. Neurobiol Aging; 1996 Feb 15; 17(6):921-33. PubMed ID: 9363804 [Abstract] [Full Text] [Related]
19. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K. Am J Pathol; 1994 Feb 15; 144(2):337-47. PubMed ID: 8311117 [Abstract] [Full Text] [Related]